Validation of the REMA Score for Predicting Mast Cell Clonality and Systemic Mastocytosis in Patients with Systemic Mast Cell Activation Symptoms
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Background: A variable percentage of patients with systemic mast cell (MC) activation symptoms meet criteria for systemic mastocytosis (SM). We prospectively evaluated the clinical utility of the REMA score versus serum baseline tryptase (sBt) levels for predicting MC clonality and SM in 158 patients with systemic MC activation symptoms in the absence of mastocytosis in the skin (MIS). Methods: World Health Organization criteria for SM were applied in all cases. MC clonality was defined as the presence of KIT-mutated MC or by a clonal HUMARA test. The REMA score consisted of the assignment of positive or negative points as follows: male (+1), female (–1), sBt <15 µg/l (–1) or >25 µg/l (+2), presence (–2) or absence (+1) of pruritus, hives or angioedema and presence (+3) of presyncope or syncope. Efficiency of the REMA score for predicting MC clonality and SM was assessed by receiver operating characteristic (ROC) curve analyses and compared to those obtained by means of sBt levels alone. Results: Molecular studies revealed the presence of clonal MC in 68/80 SM cases and in 11/78 patients who did not meet the criteria for SM. ROC curve analyses confirmed the greater sensitivity and a similar specificity of the REMA score versus sBt levels (84 vs. 59% and 74 vs. 70% for MC clonality and 87 vs. 62% and 73 vs. 71% for SM, respectively). Conclusions: Our results confirm the clinical utility of the REMA score to predict MC clonality and SM in patients suffering from systemic MC activation symptoms without MIS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indirect signs for the presence of an underlying (occult) SM include an elevated baseline serum tryptase level detected well after complete resolution of all symptoms or a D816V KIT mutation in circulating blood leukocytes, blood count abnormalities (e.g., eosinophilia), symptoms suggestive of SM such as unexplained osteoporosis, gastrointestinal symptoms (diarrhea, abdominal cramps, malabsorption”
From Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome (2019) · cites this paper as [60]
In the citing paper
“The most commonly used and validated is the REMA-score (Red Española de Mastocitosis (Spanish Network on Mastocytosis)) [57], which was initially developed for Hymenoptera venom allergy and later extended to other causes of anaphylaxis.”
From Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders (2023) · cites this paper as [57]
In the citing paper
“The Spanish Network on Mastocytosis score (REMAs) is a validated tool based on combined clinical and laboratory criteria to predict underlying MC clonality risk in patients presenting with anaphylaxis without typical mastocytosis skin changes.12,13”
From Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders (2024) · cites this paper as [12]
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Sampson, H. A., Muñoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Bock, S. A., Branum, A., Brown, S. G. A., Camargo, C. A., Cydulka, R., Galli, S. J., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.12.1303 · Cited by 2,313
Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750
Self-citationGarcia-Montero, A. C. (2006) · Blood · doi:10.1182/blood-2006-04-015545 · Cited by 504
Self-citationMast cell activation syndrome: Proposed diagnostic criteria
Akin, C., Valent, P., & Metcalfe, D. D. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.08.035 · Cited by 327
Álvarez-Twose, I., González de Olano, D., Sánchez-Muñoz, L., Matito, A., Esteban-López, M. I., Vega, A., Mateo, M. B., Alonso Díaz de Durana, M. D., de la Hoz, B., del Pozo Gil, M. D., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.02.019 · Cited by 294
Self-citationEscribano, L., Álvarez-Twose, I., Sánchez-Muñoz, L., Garcia-Montero, A., Núñez, R., Almeida, J., Jara-Acevedo, M., Teodósio, C., García-Cosío, M., Bellas, C., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.003 · Cited by 292
Self-citationEscribano, L., Diaz‐Agustin, B., López, A., Núñez López, R., García‐Montero, A., Almeida, J., Prados, A., Angulo, M., Herrero, S., Orfao, A., et al. (2004) · Cytometry Part B: Clinical Cytometry · doi:10.1002/cyto.b.10072 · Cited by 147
Self-citationWu, Y., Basir, Z., Kajdacsy-Balla, A., Strawn, E., Macias, V., Montgomery, K., & Guo, S.-W. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(02)04821-5 · Cited by 114
Cited by
Items 101–198 of 198
Treatment of idiopathic anaphylaxis with dupilumab: a case report
Pepper, E., & Pittman, L. M. (2023) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-023-00838-8 · Cited by 9
Cypress Pollen Allergy in a Mediterranean Area
Marchuet, M. J. C., Luengo, O., & Cardona, V. (2019) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0444 · Cited by 9
Machado, A., Pires, R., Martins, R., & Grumach, A. S. (2017) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0175 · Cited by 9
Álvarez‐Twöse, I., Matito, A., Sánchez‐Muñoz, L., Morgado, J. M., Orfao, A., Escribano, L., van Doormaal, J. J., van der Veer, E., Vader, P. C. V. V., Kluin, P. M., et al. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02850.x · Cited by 9
Self-citationDetection of clonal mast cell disease in wasp venom allergic patients with normal tryptase
Onnes, M. C., Alheraky, A., Nawijn, M. C., Sluijter, T. E., Mulder, A. B., Arends, S., & Oude Elberink, H. N. G. (2022) · Clinical and Translational Allergy · doi:10.1002/clt2.12174 · Cited by 8
Hoermann, G., Orfao, A., Lyons, J. J., Chantran, Y., Broesby‐Olsen, S., Sabato, V., & Arock, M. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.07.055 · Cited by 8
Self-citationEffect of Gender and Special Considerations for Women in Mastocytosis and Anaphylaxis
Ellingwood, S., & Kovalszki, A. (2023) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2023.04.004 · Cited by 8
Urra, J. M., Pérez‐Lucendo, I., Extremera, A., Feo-Brito, F., & Alfaya, T. (2019) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0442 · Cited by 8
Management of adult mastocytosis
Álvarez‐Twöse, I., Matito, A., Sánchez‐Muñoz, L., Morgado, J. M., & Escribano, L. (2014) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2014.884922 · Cited by 8
Self-citationMauro, P. D., Anzivino, R., Distefano, M., & Borzì, D. D. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117541 · Cited by 7
Jakob, T., Rafei-Shamsabadi, D. A., Spillner, E., & Müller, S. (2017) · Allergo Journal · doi:10.1007/s15007-017-1315-y · Cited by 7
Ben‐Shoshan, M., Cem, A., Cook, V. E., Khalaf, R., & Freigeh, G. E. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.08.019 · Cited by 6
Tryptase : un dosage, une formule, plusieurs indications
François, S., Collet, E., Nicaise‐Roland, P., & Chabane, H. (2022) · Revue française d'allergologie · doi:10.1016/j.reval.2022.03.011 · Cited by 6
Pediatric idiopathic anaphylaxis: practical management from infants to adolescents
Mori, F., Saretta, F., Giovannini, M., Gelsomino, M., Liotti, L., Barni, S., Mastrorilli, C., Pecoraro, L., Castagnoli, R., Arasi, S., et al. (2024) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-024-01712-y · Cited by 6
Anaphylaxis with clonal mast cells in normal looking skin – a new entity?
Bretterklieber, A., Beham‐Schmid, C., Sturm, G. J., Berghold, A., Brezinschek, R. I., Aberer, W., & Aberer, E. (2015) · Allergy · doi:10.1111/all.12634 · Cited by 6
Refractory intraoperative hypotension with elevated serum tryptase
Šprung, J., Larson, K. J., Divekar, R. D., Butterfield, J. H., Schwartz, L. B., & Weingarten, T. N. (2015) · Asia Pacific Allergy · doi:10.5415/apallergy.2015.5.1.47 · Cited by 6
Diagnosis and Treatment of Anaphylaxis in Patients with Mastocytosis
Valent, P., Akin, C., & Arock, M. (2014) · Current Treatment Options in Allergy · doi:10.1007/s40521-014-0021-1 · Cited by 6
Management of indolent mastocytosis and mast cell activation syndrome
Akin, C., Butterfield, J. H., Castells, M., & Lyons, J. J. (2025) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2025.06.032 · Cited by 5
Update in stinging insect hypersensitivity
Golden, D. B. K. (2025) · Allergy and Asthma Proceedings · doi:10.2500/aap.2025.46.250060 · Cited by 5
Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation
Hartmann, K., Álvarez‐Twöse, I., Bernstein, J. A., Akin, C., Myers, B., Hirdt, A., Whyte, A. F., Anderson, J., Ruëff, F., Siebenhaar, F., et al. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.10.010 · Cited by 5
(2021) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-021-00519-4 · Cited by 5
The Role of KIT Mutations in Anaphylaxis
Coulson, E., Zhou, S., & Akin, C. (2019) · Current Allergy and Asthma Reports · doi:10.1007/s11882-019-0863-5 · Cited by 5
Treatment of Refractory Mastocytic Enterocolitis with Budesonide
Kuruvilla, M. E., Mathew, S., & Avadhani, V. (2018) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld.2014.1121.273.dha · Cited by 5
Allergie au venin d’hyménoptère, désordres mastocytaires clonaux et alpha-tryptasémie héréditaire
Chatain, C., & van der Brempt, X. (2021) · Revue française d'allergologie · doi:10.1016/j.reval.2021.10.007 · Cited by 5
Diagnosis and management of mast cell activation syndrome (MCAS) in Canada: a practical approach
Lee, E. Y., & Picard, M. (2025) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-025-00998-9 · Cited by 4
The evaluation, management, and future of indolent systemic mastocytosis
Syal, A., Toh, J., McInerney, A., & Tremblay, D. A. (2025) · Annals of Hematology · doi:10.1007/s00277-025-06475-y · Cited by 4
Allergen-Immuntherapie: Facts und FAQs
Mortasawi, V., & Pfützner, W. (2021) · Der Hautarzt · doi:10.1007/s00105-021-04872-8 · Cited by 4
Utility of tryptase genotyping in the screening, diagnosis, and management of systemic mastocytosis
McMurray, J. C., Schornack, B. J., Villar, J., George, T. I., & Boggs, N. A. (2025) · Frontiers in Allergy · doi:10.3389/falgy.2025.1599358 · Cited by 4
Abordagem diagnóstica e terapêutica das mastocitoses – Uma proposta de orientação clínica
Rama, T. A., Moreira, A. L., & Delgado, L. (2020) · Revista Portuguesa de Imunoalergologia · doi:10.32932/rpia.2020.03.030 · Cited by 4
Billard-Larue, C., Tomé, P., & Nemni, A. (2020) · Revue française d'allergologie · doi:10.1016/j.reval.2020.02.238 · Cited by 4
Exploration biologique des mastocytoses et des syndromes d’activation mastocytaire
Brun, M., Sarrat, A., & Vitte, J. (2017) · Revue française d'allergologie · doi:10.1016/j.reval.2017.08.008 · Cited by 4
Chatain, C., Boccon‐Gibod, I., Bouillet, L., & Leccia, M. ‐. (2017) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2017.08.292 · Cited by 4
Pearls for practice from the 2023 joint task force anaphylaxis practice parameter
Maddukuri, C., Kartha, N., Conway, A. E., & Shaker, M. S. (2024) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001397 · Cited by 3
How to Recognise Mastocytosis?
Grattan, C. E. H., Broesby‐Olsen, S., & Brockow, K. (2025) · Clinical & Experimental Allergy · doi:10.1111/cea.14608 · Cited by 3
Initial False-Negative Specific IgE to Gelatin in Gelatin-Induced Anaphylaxis
Breynaert, C. M., Hoeyveld, E. V., Bullens, D. M. A., & Schrijvers, R. (2017) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0187 · Cited by 3
Risk factors in bee and Vespula venom allergy: state of the art
Stoevesandt, J., & Trautmann, A. (2021) · Allergo Journal International · doi:10.1007/s40629-021-00187-1 · Cited by 3
Cofacteurs de l’anaphylaxie : analyse des données du Réseau d’Allergo-Vigilance (2016–2020)
Bradatan, E., Sabouraud, D., Pouessel, G., & Beaudouin, É. (2022) · Revue française d'allergologie · doi:10.1016/j.reval.2021.12.011 · Cited by 3
Cuevas-Bravo, C., Guerrero, A. J., Noguerado-Mellado, B., Pérez‐Ezquerra, P. R., & Tornero, P. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.05.021 · Cited by 3
Fixed Eruption by Multiple Plant Foods
Carbonell, A., Miralles, J., Escudero, A., Cardona, P., González, A., & Navarro, C. (2017) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0176 · Cited by 3
Protein Contact Dermatitis to Chrysanthemum
Nahas, O., Colomb, S., Demoly, P. M., & Bourrain, J. ‐. (2017) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0172 · Cited by 3
Diagnosis of mastocytosis: emerging iceberg?
Rossignol, J., & Arock, M. (2024) · Blood · doi:10.1182/blood.2024024943 · Cited by 3
Crupi, F., Caroprese, J., & Mannelli, F. (2025) · Frontiers in Allergy · doi:10.3389/falgy.2025.1592001 · Cited by 2
Brunetto, S., Buta, F., Gangemi, S., & Ricciardi, L. (2025) · Frontiers in Allergy · doi:10.3389/falgy.2025.1583909 · Cited by 2
Exercise-induced anaphylaxis with an Ayurvedic drug as cofactor: A case report
Losa, F., Deidda, M., Firinu, D., Martino, M. L. D., Barca, M. P., & Giacco, S. D. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i5.623 · Cited by 2
Perčič, S., Kukec, A., & Košnik, M. (2020) · Slovenian Medical Journal · doi:10.6016/zdravvestn.2973 · Cited by 2
Hymenoptera anaphylaxis and mast cell activation disorders
González‐de‐Olano, D., & Álvarez‐Twöse, I. (2025) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000001088 · Cited by 2
Self-citationMastocytosis as a risk factor for insect venom allergy
Bonadonna, P., Boni, E., & Zanotti, R. (2020) · Allergo Journal International · doi:10.1007/s40629-020-00120-y · Cited by 2
La previsión del futuro en la empresa
de Aizpuru, M. A. T. (1987) · Dialnet (Universidad de la Rioja) · Cited by 2
Stoevesandt, J., Hain, J., & Trautmann, A. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.10.054 · Cited by 2
Mast cell activation diseases and chronic spontaneous urticaria: Common points and differences
Madelon, A., Boccon‐Gibod, I., Mansard, C., Deroux, A., Bocquet, A., & Bouillet, L. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.09.016 · Cited by 1
Predictors of Clonality and Underlying Mastocytosis in Mast Cell Activation Syndromes
González‐de‐Olano, D., & Álvarez‐Twöse, I. (2024) · Current Allergy and Asthma Reports · doi:10.1007/s11882-023-01122-w · Cited by 1
Self-citationCavara, M., Botta, A., Gallo, A. C., Bono, E., Ratti, C. P., Iemoli, E., & Ortolani, V. G. R. (2025) · Allergologie select · doi:10.5414/alx02593e · Cited by 1
Doll, R. J., Jhaveri, D. K., & Hostoffer, R. (2017) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2017.10.030 · Cited by 1
Lippert, U. (2016) · Springer eBooks · doi:10.1007/978-3-319-33142-3_22 · Cited by 1
Idiopathic Anaphylaxis—A Diagnostic and Therapeutic Dilemma
Kim, J. K., & Khan, D. A. (2015) · Current Treatment Options in Allergy · doi:10.1007/s40521-015-0059-8 · Cited by 1
Mastocytose et anaphylaxie aux venins d’hyménoptères
Lavigne, C., Lozac’h, P., & Drouet, M. (2017) · Revue française d'allergologie · doi:10.1016/j.reval.2017.08.004 · Cited by 1
Scoliid Wasp Sting: A New Cause of Anaphylaxis
Montagni, M., Peveri, S., Incorvaia, C., & Savi, E. (2017) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0186 · Cited by 1
Venom anaphylaxis can mimic other serious conditions and disclose important underlying disease
Kjær, H. F., Kristensen, T. K., Mortz, C. G., Vestergaard, H., Møller, M. B., Bindslev‐Jensen, C., & Broesby‐Olsen, S. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2017.12.022 · Cited by 1
Antolín‐Amérigo, D., Álvarez‐Perea, A., & Fiandor, A. M. (2018) · Current Treatment Options in Allergy · doi:10.1007/s40521-018-0155-7 · Cited by 1
Systemic mastocytosis in medical practice
Universitatea de Medicină și Farmacie „Carol Davila“, B., Mirică, R. E., Institutul Național de Expertiză Medicală și Recuperare a Capacității de Muncă, B., Soare, I., & Facultatea de Medicină, U. „. M. (2020) · Romanian Journal of Medical Practice · doi:10.37897/rjmp.2020.2.6 · Cited by 1
Scratching the Itch: Managing Recurrent Pruritic Skin Conditions
Johal, K. J., & Akin, C. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.01.002 · Cited by 1
The correct usage of the term “low-birth-weight infant”
Çizmeci, M. N., Akelma, A. Z., Kanburoğlu, M. K., & Mete, E. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.11.025 · Cited by 1
Systemic mast cell disease: diagnosis and management
Radia, D. H. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316017852.013
Reversible Hypogammaglobulinemia in 2 Pediatric Patients With Primary Immunodeficiency
Pasic, S. (2017) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0173
Palpebral Edema and Eosinophilia
Alcalde, J. M., Ballesteros, S. C., & Villamuza, Y. G. (2017) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0183
Mast Cell Activation Syndromes and Environmental Exposures
González‐de‐Olano, D., Domínguez‐Ortega, J., & Sánchez-García, S. (2018) · Current Treatment Options in Allergy · doi:10.1007/s40521-018-0151-y
Self-citationVenom Allergy and Management in Mastocytosis
Bonadonna, P., & Zanotti, R. (2019) · Springer eBooks · doi:10.1007/978-3-030-27820-5_10
Unusual Urticaria Pigmentosa in an Asian Man With Indolent Systemic Mastocytosis: A Case ReportPreprint
Wongsa, C., Sompornrattanaphan, M., Thongngarm, T., Owattanapanich, W., Sitthinamsuwan, P., Sukpanichnant, S., & Sukakul, T. (2020) · doi:10.21203/rs.3.rs-96587/v1
Les facteurs de risque et cofacteurs de l'anaphylaxie
Beaudouin, É., Tanno, L. K., Pouessel, G., & Demoly, P. M. (2021) · Revue française d'allergologie · doi:10.1016/s1877-0320(21)00436-x
Risikofaktoren bei Bienen- und Wespengiftallergie: aktuelle Bewertung
Stoevesandt, J., & Trautmann, A. (2022) · Allergo Journal · doi:10.1007/s15007-021-4938-y
Livideanu, C. B., Lairez, O., & Paul, C. F. (2021) · Springer eBooks · doi:10.1007/978-3-030-54779-0_20
Mastocytosis as a risk factor for insect venom allergy
Bonadonna, P., Boni, E., & Zanotti, R. (2020) · Allergo Journal · doi:10.1007/s15007-020-2516-3
Evaluation and diagnosis of mast cell–associated disorders
Park, Y. H., & Lyons, J. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95061-9.00020-5
Características das reações anafiláticas por himenóptero em um hospital terciário entre 2016 e 2022
Olguin, Y. F., Ribeiro, M. R., Andrade, M. E. B., & Rodrigues, F. F. (2023) · Revista Científica do Iamspe · doi:10.59752/rci.v12i4.167
Jiang, M., Lebovic, G., Hicks, L. K., Trinkaus, M. A., Nikonova, A., & Vadas, P. (2024) · Research Square · doi:10.21203/rs.3.rs-4356220/v1
Transforming Management of Indolent Systemic Mastocytosis With Precision Medicine
Humphry, N. (2024) · EMJ Allergy & Immunology · doi:10.33590/emjallergyimmunol/gcoo5974
Hymenoptera venom allergy – general data and case discussion
Nedelea, I., Dobrican, C. T., Bălan, R.-G., Muntean, A. M., & Deleanu, D. M. (2024) · Alergologia · doi:10.26416/aler.8.2.2024.9780
The value of serum triptase in hymenoptera venom allergy
Popa, M. D., Muntean, A. M., & Deleanu, D. M. (2024) · Alergologia · doi:10.26416/aler.8.3.2024.10137
Jiang, M., & Vadas, P. (2025) · Canadian allergy & immunology today. · doi:10.58931/cait.2025.5179
French guidelines for the management of nonadvanced mastocytosis in adults
Livideanu, C. B., Barète, S., Damaj, G. L., Arock, M., Rossignol, J., & Hermine, O. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-03764-7
Allergy to insect stings - clear rules, but also new questions
Vachová, M. (2025) · Vnitřní lékařství · doi:10.36290/vnl.2025.067
The REMA Score Revisited: An Optimized Algorithm for Early Prediction of Clonal Mast Cell Disease
Sucre-Adrianza, I., Caligaris, H., Morales‐Cabeza, C., Navarro‐Navarro, P., Sánchez‐Muñoz, L., Pérez‐Pons, A., Henriques, A., González-Tablas, M., González‐López, Ó., Recuero‐Pradillo, M., et al. (2026) · Allergy · doi:10.1111/all.70379
Self-citationSafety of Drug Provocation Tests in Adults With and Without Clonal Mast Cell Disorders
Nalin, F., Olivieri, B., Olivieri, F., Olivieri, E., Zanotti, R., Tanasi, I., Bernardelli, A., Bonifacio, M., Norelli, F., Marta, G., et al. (2025) · Allergy · doi:10.1111/all.70113
DIAGNOSIS OF CLONAL MAST CELL DISEASE IN PATIENTS WITH ANAPHYLAXIS
Álvarez‐Twöse, I., Jara‐Acevedo, M., Poladura, B., Sandoval-Arroyo, R., Lampson, B., Shaheen, D., & Orfao, A. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.anai.2025.08.033
Self-citationUnderstanding Hymenoptera Venom Allergy: Key Concepts and Clinical Approaches
Vicens-Novell, G., Fuentes, A. P., Delgado, P. S., & Ruiz-León, B. (2025) · Current Treatment Options in Allergy · doi:10.1007/s40521-025-00403-1
Jara‐Acevedo, M. (2016) · Gredos (University of Salamanca)
Self-citationÉtude de pratique : tryptasémie au CHU Grenoble Alpes et indications recommandées
Gendron, S. (2024) · HAL
Abordaje de las reacciones de hipersensibilidad a medicamentos en pacientes de Alta Complejidad
Solares, E. J. S. (2024) · e_Buah
Anaphylaxis in the Elderly: A Neglected Population
Carbone, A., Ventura, M. T., Boni, E., Buquicchio, R., & Giuliano, A. F. M. (2026) · Current Treatment Options in Allergy · doi:10.1007/s40521-026-00414-6
If It Is Not Immunoglobulin E-Mediated Allergy, What Is It?
Johnston, S. L., & Madrigal‐Burgaleta, R. (2026) · British Journal of Hospital Medicine · doi:10.31083/bjhm52244
Premières étapes dans l'interaction hôte-pathogène : rôle de l'immunité locale et innée
Michel, M. (2022) · theses.fr (ABES) · doi:10.70675/4647f4d2zd802z40abza572z8ff228db523f
Pornsuthirat, P., Owattanapanich, W., Wongsa, C., Thongngarm, T., & Sompornrattanaphan, M. (2026) · Journal of Asthma and Allergy · doi:10.2147/jaa.s594281
Alergia a himenópteros, dificultades en el diagnóstico diferencial: a propósito de un caso
García, J. L., Prêtre, G., Cadarso, A. I., & Albajar, M. B. (2026) · Revista Alergia México · doi:10.29262/ram.v73i2.1586
Gitu, A. C., & Skiff, A. (2026) · Springer eBooks · doi:10.1007/978-1-4939-0779-3_168-2
Immune-mediated drug reaction to indocyanine green: a red light for a green dye
Toscano, A., Ebo, D. G., Beyens, M. M. J., Houdt, M. V., Mertens, C. M., & Sabato, V. (2026) · European Annals of Allergy and Clinical Immunology · doi:10.23822/eurannaci.1764-1489.456
Hereditary alpha-tryptasemia: ten years on
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-8910-6
Martins, A. R. M. P. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Elst, J., Puysseleyr, L. P. D., Ebo, D. G., Faber, M. A., Gasse, A. L. V., van der Poorten, M.-L. M., Decuyper, I. I., Bridts, C. H., Mertens, C., Houdt, M. V., et al. (2022) · doi:10.3389/fimmu.2022.835618.s002
Metadata
- Authors
- Alvarez-Twose, I., González-de-Olano, D., Sánchez-Muñoz, L., Matito, A., Jara-Acevedo, M., Teodosio, C., García-Montero, A., Morgado, J. M., Orfao, A., & Escribano, L.
- Affiliations
- Hospital Virgen del Valle (ES)
- Universidad de Salamanca (ES)
- Venue
- International Archives of Allergy and Immunology
- Publisher
- S. Karger AG
- Published
- 2011-10-28
- Volume
- 157
- Issue
- 3
- Pages
- 275-280
- ISSN
- 1018-2438 (ISSN-L)
- 1423-0097
- OpenAlex
- W2033518553
- Cited by
- 184
- References
- 15
- Citations by year
- 2026: 3 · 2025: 19 · 2024: 16 · 2023: 13 · 2022: 18 · 2021: 15 · 2020: 14 · 2019: 16 · 2018: 11 · 2017: 23 · 2016: 6 · 2015: 9 · 2014: 11 · 2013: 4 · 2012: 5
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- International Archives of Allergy and Immunology (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Tumor Research and Treatment
- Health Sciences › Medicine › Surgery › Congenital gastrointestinal and neural anomalies
- Keywords
- systemic mastocytosis, serum tryptase, KIT mutations, pruritus, angioedema, diagnostic prediction
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Decision Support Techniques, Female, Humans, Male, Mast Cells, Middle Aged, Prospective Studies, Pruritus, ROC Curve, Sex Factors, Syncope, Urticaria, Biomarkers, Proto-Oncogene Proteins c-kit, Mastocytosis, Systemic, Tryptases, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.